Cargando…

Intraductal Papillary Mucinous Carcinoma Versus Conventional Pancreatic Ductal Adenocarcinoma: A Comprehensive Review of Clinical-Pathological Features, Outcomes, and Molecular Insights

Intraductal papillary mucinous neoplasms (IPMN) are common and one of the main precursor lesions of pancreatic ductal adenocarcinoma (PDAC). PDAC derived from an IPMN is called intraductal papillary mucinous carcinoma (IPMC) and defines a subgroup of patients with ill-defined specificities. As compa...

Descripción completa

Detalles Bibliográficos
Autores principales: Mas, Léo, Lupinacci, Renato M., Cros, Jérôme, Bachet, Jean-Baptiste, Coulet, Florence, Svrcek, Magali
Formato: Online Artículo Texto
Lenguaje:English
Publicado: MDPI 2021
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8268881/
https://www.ncbi.nlm.nih.gov/pubmed/34201897
http://dx.doi.org/10.3390/ijms22136756
_version_ 1783720454664486912
author Mas, Léo
Lupinacci, Renato M.
Cros, Jérôme
Bachet, Jean-Baptiste
Coulet, Florence
Svrcek, Magali
author_facet Mas, Léo
Lupinacci, Renato M.
Cros, Jérôme
Bachet, Jean-Baptiste
Coulet, Florence
Svrcek, Magali
author_sort Mas, Léo
collection PubMed
description Intraductal papillary mucinous neoplasms (IPMN) are common and one of the main precursor lesions of pancreatic ductal adenocarcinoma (PDAC). PDAC derived from an IPMN is called intraductal papillary mucinous carcinoma (IPMC) and defines a subgroup of patients with ill-defined specificities. As compared to conventional PDAC, IPMCs have been associated to clinical particularities and favorable pathological features, as well as debated outcomes. However, IPMNs and IPMCs include distinct subtypes of precursor (gastric, pancreato-biliary, intestinal) and invasive (tubular, colloid) lesions, also associated to specific characteristics. Notably, consistent data have shown intestinal IPMNs and associated colloid carcinomas, defining the “intestinal pathway”, to be associated with less aggressive features. Genomic specificities have also been uncovered, such as mutations of the GNAS gene, and recent data provide more insights into the mechanisms involved in IPMCs carcinogenesis. This review synthetizes available data on clinical-pathological features and outcomes associated with IPMCs and their subtypes. We also describe known genomic hallmarks of these lesions and summarize the latest data about molecular processes involved in IPMNs initiation and progression to IPMCs. Finally, potential implications for clinical practice and future research strategies are discussed.
format Online
Article
Text
id pubmed-8268881
institution National Center for Biotechnology Information
language English
publishDate 2021
publisher MDPI
record_format MEDLINE/PubMed
spelling pubmed-82688812021-07-10 Intraductal Papillary Mucinous Carcinoma Versus Conventional Pancreatic Ductal Adenocarcinoma: A Comprehensive Review of Clinical-Pathological Features, Outcomes, and Molecular Insights Mas, Léo Lupinacci, Renato M. Cros, Jérôme Bachet, Jean-Baptiste Coulet, Florence Svrcek, Magali Int J Mol Sci Review Intraductal papillary mucinous neoplasms (IPMN) are common and one of the main precursor lesions of pancreatic ductal adenocarcinoma (PDAC). PDAC derived from an IPMN is called intraductal papillary mucinous carcinoma (IPMC) and defines a subgroup of patients with ill-defined specificities. As compared to conventional PDAC, IPMCs have been associated to clinical particularities and favorable pathological features, as well as debated outcomes. However, IPMNs and IPMCs include distinct subtypes of precursor (gastric, pancreato-biliary, intestinal) and invasive (tubular, colloid) lesions, also associated to specific characteristics. Notably, consistent data have shown intestinal IPMNs and associated colloid carcinomas, defining the “intestinal pathway”, to be associated with less aggressive features. Genomic specificities have also been uncovered, such as mutations of the GNAS gene, and recent data provide more insights into the mechanisms involved in IPMCs carcinogenesis. This review synthetizes available data on clinical-pathological features and outcomes associated with IPMCs and their subtypes. We also describe known genomic hallmarks of these lesions and summarize the latest data about molecular processes involved in IPMNs initiation and progression to IPMCs. Finally, potential implications for clinical practice and future research strategies are discussed. MDPI 2021-06-23 /pmc/articles/PMC8268881/ /pubmed/34201897 http://dx.doi.org/10.3390/ijms22136756 Text en © 2021 by the authors. https://creativecommons.org/licenses/by/4.0/Licensee MDPI, Basel, Switzerland. This article is an open access article distributed under the terms and conditions of the Creative Commons Attribution (CC BY) license (https://creativecommons.org/licenses/by/4.0/).
spellingShingle Review
Mas, Léo
Lupinacci, Renato M.
Cros, Jérôme
Bachet, Jean-Baptiste
Coulet, Florence
Svrcek, Magali
Intraductal Papillary Mucinous Carcinoma Versus Conventional Pancreatic Ductal Adenocarcinoma: A Comprehensive Review of Clinical-Pathological Features, Outcomes, and Molecular Insights
title Intraductal Papillary Mucinous Carcinoma Versus Conventional Pancreatic Ductal Adenocarcinoma: A Comprehensive Review of Clinical-Pathological Features, Outcomes, and Molecular Insights
title_full Intraductal Papillary Mucinous Carcinoma Versus Conventional Pancreatic Ductal Adenocarcinoma: A Comprehensive Review of Clinical-Pathological Features, Outcomes, and Molecular Insights
title_fullStr Intraductal Papillary Mucinous Carcinoma Versus Conventional Pancreatic Ductal Adenocarcinoma: A Comprehensive Review of Clinical-Pathological Features, Outcomes, and Molecular Insights
title_full_unstemmed Intraductal Papillary Mucinous Carcinoma Versus Conventional Pancreatic Ductal Adenocarcinoma: A Comprehensive Review of Clinical-Pathological Features, Outcomes, and Molecular Insights
title_short Intraductal Papillary Mucinous Carcinoma Versus Conventional Pancreatic Ductal Adenocarcinoma: A Comprehensive Review of Clinical-Pathological Features, Outcomes, and Molecular Insights
title_sort intraductal papillary mucinous carcinoma versus conventional pancreatic ductal adenocarcinoma: a comprehensive review of clinical-pathological features, outcomes, and molecular insights
topic Review
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8268881/
https://www.ncbi.nlm.nih.gov/pubmed/34201897
http://dx.doi.org/10.3390/ijms22136756
work_keys_str_mv AT masleo intraductalpapillarymucinouscarcinomaversusconventionalpancreaticductaladenocarcinomaacomprehensivereviewofclinicalpathologicalfeaturesoutcomesandmolecularinsights
AT lupinaccirenatom intraductalpapillarymucinouscarcinomaversusconventionalpancreaticductaladenocarcinomaacomprehensivereviewofclinicalpathologicalfeaturesoutcomesandmolecularinsights
AT crosjerome intraductalpapillarymucinouscarcinomaversusconventionalpancreaticductaladenocarcinomaacomprehensivereviewofclinicalpathologicalfeaturesoutcomesandmolecularinsights
AT bachetjeanbaptiste intraductalpapillarymucinouscarcinomaversusconventionalpancreaticductaladenocarcinomaacomprehensivereviewofclinicalpathologicalfeaturesoutcomesandmolecularinsights
AT couletflorence intraductalpapillarymucinouscarcinomaversusconventionalpancreaticductaladenocarcinomaacomprehensivereviewofclinicalpathologicalfeaturesoutcomesandmolecularinsights
AT svrcekmagali intraductalpapillarymucinouscarcinomaversusconventionalpancreaticductaladenocarcinomaacomprehensivereviewofclinicalpathologicalfeaturesoutcomesandmolecularinsights